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Mesopontine cholinergic neurons have long been thought to play a key role in behavioral state control. In particular, they have been implicated in the process of EEG desynchrony and in the generation of rapid eye movement (REM) sleep. However, the behavioral profile of identified mesopontine cholinergic neurons has not been unequivocally demonstrated. In an attempt to address this issue, in viva microdialysis was used to monitor acetylcholine (ACh) release across behavioral state in the rat thalamus, a major projection site of mesopontine cholinergic neurons. Because REM periods in rats are of short duration, a method was developed to collect and accumulate sufficiently large samples from each of the individual states of wake, slow-wave sleep, and REM sleep to permit off-line analysis via (HPLC-ECD). Probe placement and the source of cholinergic innervation to the vicinity of the microdialysis probe were verified using retrograde tracing combined with ChAT immunohistochemistry. Finally, the sodium and calcium dependence of ACh measured in the thalamus were tested using TTX and calcium-free dialysates. The results showed that (1) extracellular ACh concentrations in the thalamus are high during both wake and REM sleep and significantly lower during slow-wave sleep, (2) the majority of cholinergic projections to the vicinity of the dialysis probes originate in the mesopontine tegmentum, and (3) ACh release in the thalamus is due to sodium-and calcium-dependent mechanisms.
In contrast to predictions of some previous hypotheses, these results demonstrate that mesopontine cholinergic neurons are active during both wake and REM sleep.
[Key words: ACh, mesopontine cholinergic neurons, REM sleep, behavioral state control, EEG, microdialysis] Mesopontine cholinergic neurons are thought to have important roles in EEG desynchrony and in the generation of rapid eye movement (REM) sleep. This notion has been supported by a large body of work originating with Moruzzi and Magoun (1949) , who found that eliciting EEG desynchrony by electrical stimulation in the brainstem was most effective when the stimulating electrode was placed in the region of the mesopontine tegmen-turn. Early brainstem lesion studies showed that lesions at the midbrain-pontine junction abolished EEG desynchrony during wake (Lindsley et al., 1949 (Lindsley et al., , 1950 Batini et al., 1959; Jouvet, 1962; Hobson, 1965) , and reduced the phasic activity normally observed during REM sleep, including rapid eye movements, PGO waves, and muscle atonia (Jouvet, 1962; Hobson, 1965) . It was later shown by means of acetylcholinesterase (AChE) histochemistry and from choline acetyltransferase (ChAT) immunohistochemistry that the brainstem cholinergic neurons are localized in the laterodorsal and pedunculopontine tegmenta (LDT, PPT, respectively; Shute and Lewis, 1967; Satoh et al., 1983; Jones and Beaudet, 1987; Vincent and Reiner, 1987) . In addition, retrograde and anterograde tracing combined with ChAT immunohistochemistry revealed that mesopontine cholinergic neurons gave rise to a massive innervation of the thalamus in rats (Sofroniew et al., 1985; Satoh and Fibiger, 1986; Woolf and Butcher, 1986; Hallanger and Wainer, 1988; Semba and Fibiger, 1992) , which is thought to control cortical EEG (Steriade et al., 1990a) . Mesopontine cholinergic neurons thus became one of the neuronal candidates for Moruzzi and Magoun's "ascending reticular activating system" (1949) . Recent brainstem lesion studies employing modern techniques to further localize damage to the LDT/PPT have suggested that mesopontine choline& neurons may be crucial to the generation of REM sleep and its associated features. Shouse and Siegel (1992) found that lesion of the PPT reduces the amount of PGO activity in REM sleep. Webster and Jones (1988) demonstrated that lesion of the LDT/PPT choline@ neurons eliminated REM sleep in some animals for up to several weeks, while in others, PGO activity and muscle atonia during REM sleep were reduced-the extent of the reduction of time spent in REM sleep and of PGO activity correlated with the extent of the loss of cholinergic neurons. Unlike earlier studies, in which lesions encompassed a much larger area (Lindsley et al., 1949 (Lindsley et al., , 1950 Batini et al., 1959; Jouvet, 1962; Hobson, 1965) , waking and EEG desynchrony were not significantly altered, which suggested that other neuronal substrates were involved in the control of waking EEG.
The importance of LDT/PPT choline& neurons in the generation of REM sleep is further supported by the ObStYvatiOn that microinjection of the cholinergic agonist carbachol into the medial pontine reticular formation (mPRF) induces a state that is indistinguishable from REM sleep (George et al., 1964; Baxter, 1969; Mitler and Dement, 1974; Amatruda et al., 1975; Gnadt and Pegram, 1986) . Anatomical data have shown that the mPRF is innervated by choline@ neurons originating in the LDT/PPT (Mitani et al., 1988; Shiromani et al., 1988; Quatrocchi et al., 1989; Jones, 1990; Semba et al., 1990; Semba, 1993) . It has therefore been hypothesized that release of ACh in the mPRF is perhaps the natural trigger for REM sleep.
The interaction of cholinergic, noradrenergic, and serotonergic neurons in the brainstem has long been suggested to be a key factor in behavioral state control (Hemandez-Peon, 1963; Jouvet, 1969; Hobson et al., 1975) . That amines inhibit AChinduced triggering of REM sleep was first suggested by the observation that systemic injection of the AChE inhibitor eserine induced a state that was indistinguishable from REM sleep, but only after depletion of amines with reserpine (Karczmar et al., 1970) . Electrophysiological recordings in the locus ceruleus and in the dorsal raphe showed that noradrenergic and serotonergic neurons are very active during wake, less so during slow-wave sleep (SWS), and silent during REM sleep McGinty and Harper, 1976; Trulson and Jacobs, 1979; AstonJones and Bloom, 198 1; Reiner, 1985) . Based upon these findings, it was hypothesized that amines have an inhibitory influence on brainstem cholinergic mechanisms (Karczmar et al., 1970; McCarley and Hobson, 1975; Sakai, 1988; Steriade and McCarley, 1990) . Indeed, recent studies have shown that noradrenaline (NA) and serotonin (5-HT) inhibit the majority of rat LDT neurons in vivo (Koyama and Kayama, 1993) as well as hyperpolarize identified mesopontine cholinergic neurons in brainstem slices in vitro (Luebke et al., 1992; Williams and Reiner, 1993) . Taken together, these data suggest that brainstem cholinergic neurons would be powerfully inhibited during wake, when both serotonergic and noradrenergic neurons are most active.
On the other hand, while the data reviewed above may suggest that mesopontine cholinergic neurons are REM specific, in vivo electrophysiological recordings in the mesopontine tegmentum have revealed that only a minority of cells fire selectively during REM sleep, and that a majority fire both during REM sleep and wake (Mansari et al., 1989; Steriade et al., 1990b; El Kayama et al., 1992) . Thus, the state-dependent activity of identified mesopontine cholinergic neurons remains unclear. In an attempt to resolve this issue, we carried out experiments using in vivo microdialysis, in which ACh release was measured across behavioral state in the rat thalamus. Several anatomical investigations have shown that the rat thalamus receives cholinergic projections exclusively from the brainstem, with the exception of the reticular nucleus, which receives cholinergic innervation from both the basal forebrain as well as the mesopontine tegmentum (Sofroniew et al., 1985; Satoh and Fibiger, 1986; Woolf and Butcher, 1986; Hallanger and Wainer, 1988; Jourdain et al., 1989) . The medial portion of the thalamus, therefore, is an ideal region to test the extent to which there is state-dependent ACh release from brainstem cholinergic neurons.
Materials and Methods
Surgery. Male wistar rats, weighing 275-390 gm, were surgically implanted with EEG recording electrodes for monitoring behavioral state and with a transverse microdialysis probe in the thalamus for measuring ACh concentrations in vivo.
Animals were anesthetized with 50-60 mg/kg pentobarbital (i.p.) and supplemented as needed. For EEG recordings, animals were chronically implanted with three screw electrodes (two for cortical EEG and one over the cerebellum as a reference) and with either nuchal electrodes for EMG or depth electrodes for the recording of hippocampal theta (AP -3.1, DV -3.0, ML -2.4 from bregma; Paxinos and Watson, 1982) . Electrode pins were held in place with an Amphenol strip connector and fixed to the skull with dental acrylic.
Transverse microdialysis probes were constructed and implanted as described in detail elsewhere (Damsma and Westerink, 199 1) . Briefly, probes were made of a Hospal Filtral AN69 microdialysis membrane (0.22 mm i.d., 0.27 mm o.d., 60,000 molecular weight cutotT) with an active surface of 7 mm. Dialysis probes were placed at steredtaxic coordinates from breama (AP -3.3. DV -5.8 to -5.6: Paxinos and Watson, 1982) , and the active surface centered to expose the ventroposterolateral, ventroposteromedial, centromedial, mediodorsal, interomediodorsal, and posterior thalamic nuclei.
Microdialysis.
Following surgery, rats were housed individually in 35 x 35 x 25 cm Plexiglas cages and were given food and water ad libitum. On the first day after surgery, each animal was moved into a secluded recording room, where they were attached to a model 78 Grass polygraph for several hours for adaptation. Experiments were performed on the second and third days after surgery during the light phase of a 12: 12 hr 1ight:dark cycle (from 0800 to 2000 hr) between 1000 and 1900 hr. Because the different behavioral states of the rat are short lived, the sample collection procedure (Damsma and Westerink, 199 1) was modified in order to achieve the purest dialysis samples possible for each of the behavioral states of wake, SWS, and REM sleep. The samples were collected as follows. The dialysis probes were perfused with artificial cerebrospinal fluid (ACSF) containing (in mM) 125 NaCl, 3 KCl, 1.3 CaCl,, 1 .O MgCl,, 23 NaHCO,, 1 .O PO, buffer, and pH balanced to 7.4 with HCl. In order to recover detectable levels of extracellular ACh, the reversible AChE inhibitor neostigmine bromide (Sigma) was added to the ACSF (100 nM). The dialysis membrane was perfused at a rate of 5 pl/min, controlled by a syringe pump (Harvard Apparatus). The probe inlet was connected to the syringe by polyethylene tubing (800 cm x 0.28 mm: 50 ILL in volume). The outlet Dolvethvlene tubing was also cut to a 50 ~1 volume length'and weighted at-the end with altted short piece of Tygon tubing.
For the behavioral experiments, all dialysate samples were collected into ice-cold microcentrifuge tubes marked "wake," "SWS," or "REM." Each vial contained 5 ~1 of 0.4% acetic acid in order to stabilize the ACh collected in the dialysate. No more than 100 ~1 of dialvsate was allowed to accumulate in each vial in order to maintain equal concentrations of acetic acid for each of the behavioral states. As the animals shifted from wake to SWS to REM, each state was timed and a 10 min 30 set delay was added to allow the perfusate to move from the animal to the end of the output tubing.
Samples that were collected in the "wake" vials included periods in which the animal was clearly alert with a desynchronized EEG and engaged in some sort of waking behavior such as grooming, eating, drinking, or exploring. "SWS" vials included periods in which the animal was in a sleeping position, eyes closed, and the EEG synchronized for >30 set at a time. "REM" vials included the sleep state in which the animal exhibited muscle twitches, EEG desynchrony, and theta activity. All samples from ambiguous and transition states were discarded.
Prior to sample collection, animals were dialyzed for 40-60 min in order to allow the brain to equilibrate with the perfusion solution. Samples were collected during 5-6 hr sessions and were stored in an ice bucket for off-line analysis via high-performance liquid chromatography in coniunction with electrochemical detection (HPLC-ECD) immediately after the session.
To test for the sodium and calcium dependence of thalamic ACh release, animals were attached directly to the HPLC system for on-line analysis of ACh release. Once steady baseline levels were achieved, animals were perfused either with solution containing 1 PM tetrodotoxin (TTX: Siama) or with calcium-free oerfusate for at least 30 min.
A&y ofackylcholine.
For the offlline experiments, dialysis samples were manually injected into a 50 ~1 sample loop of the analytical system with a 100 ~1 Hamilton syringe. For the on-line experiments, the output tubing was connected directly to the sample loop, and perfusate was injected at 10 min intervals controlled by an adjustable timer (Valco). Standards (lo-' M ACh) were injected hourly into a separate 20 ~1 sample loop.
The assay of ACh via HPLC-ECD was performed in conjunction with an enzyme reactor (Damsma et al., 1987) . Briefly, after separation of ACh and choline (Ch) with a reverse phase column (75 x 2.1 mm) pretreated with lauryl sulfate, the eluent was then passed through an enzyme reactor (10 x 2.1 mm) containing acetylcholinesterase (EC 3.1.1.7; Sigma, type VI-S) and choline oxidase (1.1.3.17; Sigma) covalently bound to alutaraldehvde-activated Lichrosorb NH, (10 urn: Merck). The reaction of ACh and Ch with these enzymes produced a quantitative yield of hydrogen peroxide, which was electrochemically detected at a platinum working electrode set at a potential of + 500 mV versus an Ag/AgCl reference electrode (BAS-LC4B or ANTEC VT-03). An HPLC pump (LKB-2 150 or Shimadzu LC-600) delivered the mobile phase (0.2 M aqueous potassium phosphate buffer pH 8.0, 1 mM tetramethylammonium hydroxide) at a rate of 0.4 ml/min. Chromatograms were drawn on a chart recorder (Kipp); hydrogen peroxide peaks corresponding to ACh normally appeared 4-5 min after the initial solvent front. The detection limit of the assay was 50 fmol per injection.
Immunohistochemistry. Probe placement was verified in four rats using standard techniques, while in six rats, the source of cholinergic innervation to the orobe was also verified using Fluoro-Gold (FG) as a retrograde tracer (4% in 0.9% saline) and ChATimmunohistochemistry. FG was manually injected into the dialysis probe and rinsed out with normal perfusion solution after 24 hr. After 5-l 4 d, animals were anesthetized with an overdose of sodium pentobarbital and transcardially perfused with 100 ml of 0.9% saline followed by 300 ml of 4% paraformaldehvde in 0.1 M Dhosnhate buffered saline (PBS). The brains were removed and postfixed at 4°C for 2 hr and then transferred to 15% sucrose in 0.1 M PBS and stored overnight at 4°C. The next day, brains were cut into 30 Nrn coronal sections on a freezing microtome and every fifth section separated into wells containing 0.1 M PBS.
Sections that contained the site ofthe probe were mounted onto coated slides immediately for verification of placement. Ten cortical sections containing basal forebrain cholinergic neurons, and 10 brainstem sections containing LDT/PPT choline@ neurons were selected and processed for ChAT immunohistochemical staining as follows. The 20 sections were placed in a solution composed of 1:50 normal goat serum (Jackson Immunoresearch Laboratories, Inc.), 0.02Oh sodium azide, and 1:50 rat anti-ChAT antibody (Boehringer-Mannheim) in 0.1 M PBS containing 0.3% Triton and incubated for 2 nights at 4°C. Sections were washed 3 x 20 min in PBS and then incubated at room temperature for 2 hr in 1:20 Texas red-conjugated goat anti-rat antibody (Jackson Immunoresearch Laboratories, Inc.) in 0.3% T&on/PBS. After the 2 hr period, slices were washed again for 3 x 20 min in 0.1 M PBS and mounted onto coated slides for inspection using fluorescence microscopy.
For identifying and quantifying double-labeled cells, basal forebrain and brainstem sections were photographed twice: once using green light (530-560 nm) to visualize the Texas red-labeled choline@ neurons, and once using ultraviolet light (340-380 nm) to visualize the retrogradely labeled cells. Negatives obtained under the green light were projected onto 8.5 x 11 inch sheets of paper, onto which the individual choline& cells were traced. Afterward, the corresponding exposures under ultraviolet fluorescence were projected onto the drawing for identification of double-labeled cells by the superimposed images of the retrogradely labeled neurons. 
Results
Thalarnic acetylcholine release In order to determine whether ACh release in the thalamus was the result of action potential-dependent neuronal activity, we carried out two experiments. First, TTX (1 PM) was added to the perfusion solution to block voltage-dependent sodium channels. TTX significantly reduced extracellular ACh concentrations in two of two rats from an average baseline of 18.2 1 + 5.82 to 2.12 f 1.31 fmol/min (t = 7.62, p < 0.0001). Second, two other rats were perfused with calcium-free ACSF in order to abolish Ca*+-dependent synaptic transmission. The calciumfree solution significantly reduced the baseline ACh concentrations in two of two rats from 15.75 -t 7.25 to 3.5 1 f 0.75 fmol/ min (t = 5.57, p < 0.000 I). These results confirm that thalamic ACh release was due to sodium-and calcium-dependent mechanisms, as opposed to overflow of extracellular neurotransmitter caused by trauma from the probe implant (Westerink and De Vries, 1988) . The number of 50 ~1 samples obtained on any particular day for each rat varied between the behavioral states of wake, SWS, and REM. An average of 4.93 + 2.72 samples were obtained for wake, 5.13 f 2.00 for SWS, and 1.53 f 0.50 for REM on each day. Because most of the samples within each state for each rat were very similar, within-state samples were averaged for each experimental day. A total of 15 sample values for each behavioral state were obtained in 10 rats. These values and their standard deviations are reported in Table 1. The average ACh concentration during wake was 18.01 + 8.58 fmol/min; during SWS, 8.17 f 2.55 fmol/min; and during REM, 19.52 f 9.36 fmol/min (Fig. 1) . Analysis of variance In vitro recovery of acetylcholine The average duration of the REM periods across the 10 rats used in this study was 92.28 + 57.87 sec. Because the REM periods were short lived, we tested our sample collection technique in vitro in order to determine the extent to which the ACh concentration values obtained for REM sleep were accurate. Microdialysis probes of the type used in this study were connected to polyethylene tubing and perfused with ACSF at a rate of 5 &min (see Materials and Methods), The probe was placed in a vial containing normal ACSF and manually transferred to another vial containing 100 nM ACh for either 30-60 set (87% of the accumulated sample was obtained from intervals of 50 set or less) or 2 min intervals. In order to measure total recovery rates, the probe was left in the 100 nM ACh solution for up to 20 min. Both solutions were maintained at 37°C. Samples were collected off line, as described it Materials and Methods. Dialysis probes had an in vitro recovery of 22 f 3.39% (n = 4). Collection of 30-60 set samples reduced the recovery in one probe from 2 1% to 12%. Collection of samples from 2 min time periods reduced the recovery in another probe from 17% to 15%. These results indicate that our in vitro sampling is accurate to 89% within a 2 min time period, but only 57% accurate for time periods of 1 min or less, which suggests that the ACh concentrations measured during REM sleep periods may have been underestimated, as these samples were most likely contaminated with dialysate from SWS periods.
Immunohistochemical
verification of cholinergic innervation to the thalamus Retrograde tracing with FG resulted in many labeled cells throughout the cortex, hippocampus, basal forebrain, and brainstem. Few neurons were labeled in the medial septum, while a moderate number was found in the more caudal portions of the cholinergic basal nuclear complex, including the horizontal limb of the nucleus of the diagonal band of Broca and in the nucleus basalis of Meynert. Across six rats, a total of 4679 cholinergic cells were counted in the basal forebrain. Of these cells, only 84 or 1.80% were found to be double labeled. In contrast, 2784 ChAT-positive cells were counted in the LDT and PPT. Of these cells, 1632 or 58.62% were double labeled (Fig. 2) . Therefore, of a total number of 17 16 double-labeled neurons, brainstem cholinergic neurons accounted for an average of 94.5 f 4.19%, while the basal forebrain accounted for the remaining 5.5 -t 4.19% (Table 2 ). These results confirm that the majority of cholinergic inputs to the probe was from the brainstem cholinergic group.
Discussion
The principle finding of this study is that ACh release in the thalamus is high during both REM sleep and wake, and significantly lower during SWS. Thalamic ACh concentrations were sensitive to TTX and to calcium-free perfusate, which indicates that the release was due to action potential generation as well as calcium-dependent synaptic transmission. Furthermore, retrograde tracing with FG combined with ChAT immunohisto- For each rat, the number of double-labeled cells (FG + ChAT) versus the total number of cholinergic neurons (ChAT+) is shown for the basal forebrain and the brainstem (LDT/PPT).
Numbers in parentheses show the percentage of all choline& neurons projecting to the thalamus. These results show that the majority of inputs to the thalamic probe originated from brainstem choline@ neurons.
chemistry verified that the majority of cholinergic inputs in the vicinity of the microdialysis probe arose from the mesopontine tegmentum. These results demonstrate unequivocally that mesopontine cholinergic neurons are active during wake. Based upon the state-dependent activity of serotonergic and noradrenergic neurons McGinty and Harper, 1976; Trulson and Jacobs, 1979; Aston-Jones and Bloom, 198 1; Reiner, 1985) and the observation that NA and 5-HT inhibit identified LDT cholinergic neurons in vitro (Luebke et al., 1992; Williams and Reiner, 1993) we hypothesized that mesopontine cholinergic neurons would be profoundly inhibited during wake Williams and Reiner, 1993) . One prediction of this hypothesis is that thalamic ACh release by mesopontine cholinergic neurons would be much higher during REM sleep than during wake. The present results clearly show that this prediction is in error: thalamic ACh release during wake and REM sleep is essentially the same. Such a conclusion is in concordance with the results ofelectrophysiological studies, which suggested that mesopontine cholinergic neurons are active during EEG desynchronized states (El Mansari et al., 1989; Steriade et al., 1990b) .
The in vitro recovery rates through the dialysis probes indicated that detection of changes in ACh concentration within short time periods ranging from 30 set to 2 min was 57-89% accurate. This result suggests that the ACh concentrations measured during REM sleep may have been underestimated, as these samples may have been contaminated with dialysate from SWS periods. If this were the case, then it may be possible that ACh release is higher during REM sleep than wake. This is supported by the observation that while many LDT/PPT neurons were tonically active both during wake and REM sleep, their firing rates were significantly higher in REM sleep as compared to wake (Steriade et al., 1990b) . On the other hand, the in vitro sampling error may reflect a time constraint on the rate at which the probes could detect sudden changes in ACh concentration. Behavioral state changes were much more gradual, and as stated earlier, transition periods were discarded. Therefore, it is also possible that the sampling procedure was more accurate in vivo than the in vitro data suggest. In any case, whether extracellular ACh concentrations during REM sleep were underestimated or not, it is clear that mesopontine cholinergic neurons are active during wake as well as REM sleep. This finding is consistent with previous reports showing the state dependence of ACh release in the cortex (Kanai and Szerb, 1965; Szerb, 1967; Jasper and Tessier, 197 1) and in the hippocampus (Kametani and Kawamura, 1990) , suggesting that this behavioral profile is the same for both mesopontine and basal forebrain cholinergic neurons.
The results of the present study contrast with the current view that ACh release in the mPRF is one mechanism for the induction of REM sleep. This hypothesis is based on the observation that microinjection of the cholinergic agonist carbachol into the mPRF induces a state that is indistinguishable from REM sleep (George et al., 1964; Baxter et al., 1969; Mitler and Dement, 1974; Amatruda et al., 1975; Gnadt and Pegram, 1986, Quattrochi et al., 1989) . In vivo microdialysis of the cat mPRF has shown that extracellular ACh concentrations in the mPRF are very high in both REM sleep (Kodama et al., 1990) and in carbachol-induced REM sleep (Lydic et al., 199 1) as compared to wake. Using retrograde tracing combined with ChAT immunohistochemistry, Semba et al. (1990) found that 45-88% of mesopontine cholinergic neurons projecting to the mPRF also projected to the thalamus. Taken together with the results of the present study, these data suggest that brainstem choline& neurons may release ACh differentially with respect to region, ACh being released in the thalamus at equal rates during both wake and REM sleep, but at significantly higher rates in the mPRF during REM sleep than during wake or SWS. There are several possible mechanisms for this type of ACh release.
First, Semba et al. (1990) also reported distinct populations of brainstem cholinergic neurons that had inputs exclusively either to the thalamus or to the mPRF. This raises the possibility that cholinergic neurons projecting only to the mPRF are selectively active during REM sleep. However, this scenario is unlikely for two reasons. First, Semba et al. (1990) reported that the majority of cholinergic neurons projecting to the mPRF also projected to the thalamus. Second, electrophysiological recordings in vivo have demonstrated that the majority of LDT/PPT neurons are tonically active during wake and REM sleep (El Mansari et al., 1989; Steriade et al., 1990b; Kayama et al., 1992) . Steriade et al. (1990b) did observe a minority of cells that were selectively active during REM sleep, but it is not clear whether these were cholinergic. A second possible mechanism for differential ACh release is inhibitory axoaxonic inputs onto presynaptic cholinergic terminals in the mPRF, which would suppress ACh release during wake. Recent anatomical studies have shown that there are neurons in the pontine reticular formation that are immunoreactive for GABA (Brodal et al., 1988) or for glycine (Fort et al., 1993) . Microinjection of the GABA, agonist muscimol into the rat PRF increases the latency to SWS and to REM sleep as well as the total amount of time spent in wake. Likewise, the GABAergic antagonist bicuculline reduces the latency to SWS and to REM sleep 199 1) . These findings indicate that GABAergic neurotransmission may be involved in the sleep-wake cycle, and presynaptic inhibition of cholinergic terminals in the mPRF may be one aspect of this involvement.
In addition, the rat mPRF receives both serotonergic and (to a lesser extent) noradrenergic inputs arising from the dorsal raphe and locus ceruleus, respectively (Semba, 1993) . Semba (1993) hypothesized that waking may be "maintained" in part by the convergence ofACh, NA, and 5-HT onto mPRF neurons, and that REM sleep may be induced upon depolarization of mPRF neurons by ACh in the absence of noradrenergic and serotonergic input (Ito and McCarley, 1984) . Further studies directed at the morphology and cytochemistry of synaptic inputs to the mPRF are needed to address these issues.
In conclusion, the present study has demonstrated that ACh is released in the thalamus at equal rates during wake and REM sleep and much more slowly during SWS. This finding supports the hypothesis that mesopontine cholinergic neurons play an important role in EEG desynchronized states (Steriade et al., 1990b) . These data have important implications for the role of ascending as well as descending projections of mesopontine cholinergic neurons in behavioral state control.
